AUSTRALIAN CLINICAL LABS LIMITED - Announcements

0.54%

$2.79

Market Cap $545.9M

Healthcare Medical Care

Australian Clinical Labs Limited is a private provider of pathology services. Its... Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients and corporate clients, including chemical pathology, hematology, histopathology & cytopathology, serology & microbiology, allergy & immunology, molecular cancer testing, genetic carrier screening & other antenatal testing, cardiac testing services, veterinary pathology, functional pathology, and pathology services for clinical trials, among others. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory. Its SunDoctors brand provides skin cancer care services.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

ACL	2023 Annual Report		21/09/23	7.52MB	Share
ACL	2023 AGM - Notice of Meeting		21/09/23	1.62MB	Share
ACL	Update on offer for Healius and postponement of EGM		14/09/23	164.96KB	Share
ACL	Chair - resumption of role		12/09/23	214.03KB	Share
ACL	Ceasing to be a substantial holder		11/09/23	291.9KB	Share
ACL	HLS: Supplementary Target's Statement	PRICE SENSITIVE	05/09/23	707.84KB	Share
ACL	Becoming a substantial holder		28/08/23	816.91KB	Share
ACL	Initial Director's Interest Notice - C Bartlett		23/08/23	966.91KB	Share
ACL	Appointment of non-executive director		23/08/23	216.85KB	Share
ACL	Notification regarding unquoted securities - ACL		22/08/23	24.81KB	Share
ACL	Dividend/Distribution - ACL		22/08/23	22.48KB	Share
ACL	FY23 investor results presentation	PRICE SENSITIVE	22/08/23	1.6MB	Share
ACL	Appendix 4E and FY23 financial reports	PRICE SENSITIVE	22/08/23	2.97MB	Share
ACL	2023 AGM details		15/08/23	216.97KB	Share
ACL	FY23 financial results investor webinar		15/08/23	130.82KB	Share
ACL	HLS: ACCC Statement of Issues	PRICE SENSITIVE	20/07/23	138.1KB	Share
ACL	Takeover bid for Healius Limited - extension of offer period	PRICE SENSITIVE	20/07/23	246.68KB	Share
ACL	ACCC Statement of Issues - Offer for Healius Limited		20/07/23	347.99KB	Share
ACL	AXX: ACL's proposed acquisition of Healius raises concerns	PRICE SENSITIVE	20/07/23	204.97KB	Share
ACL	Initial Director's Interest Notice		05/07/23	231.14KB	Share
ACL	Chair to take temporary leave		04/07/23	117.79KB	Share
ACL	HLS: Directors' Statement re Takeover	PRICE SENSITIVE	23/05/23	142.59KB	Share
ACL	Response to Healius' Target's Statement	PRICE SENSITIVE	22/05/23	176.33KB	Share
ACL	Second Supplementary Bidder's Statement	PRICE SENSITIVE	22/05/23	3.05MB	Share
ACL	Takeover offer - receipt of Target's Statement		05/05/23	121.44KB	Share
ACL	HLS: Lodgement of Target's Statement	PRICE SENSITIVE	04/05/23	1.1MB	Share
ACL	Completion of dispatch of replacement bidder's statement		21/04/23	124.62KB	Share
ACL	Commencement of dispatch of replacement bidder's statement		21/04/23	6.13MB	Share
ACL	Notice of EGM		20/04/23	8.33MB	Share
ACL	TOV: HLS Panel Declines to Conduct Proceedings	PRICE SENSITIVE	17/04/23	93.48KB	Share
ACL	ASX announcement - Replacement Bidder's Statement	PRICE SENSITIVE	14/04/23	208.73KB	Share
ACL	Replacement Bidder's Statement	PRICE SENSITIVE	14/04/23	6.11MB	Share
ACL	First Supplementary Bidder's Statement	PRICE SENSITIVE	14/04/23	6.36MB	Share
ACL	Change in substantial holding		29/03/23	217.34KB	Share
ACL	Change in substantial holding		29/03/23	1.77MB	Share
ACL	TOV: HLS Panel Receives Application	PRICE SENSITIVE	29/03/23	114.08KB	Share
ACL	Update - Dividend/Distribution - ACL		28/03/23	26.27KB	Share
ACL	Becoming a substantial holder		27/03/23	374.34KB	Share
ACL	Suspension of DRP		27/03/23	121.92KB	Share
ACL	HLS: Directors' Statement re Takeover	PRICE SENSITIVE	27/03/23	171.75KB	Share
ACL	Proposed issue of securities - ACL		22/03/23	25.31KB	Share
ACL	Becoming a substantial holder for HLS		20/03/23	98.17KB	Share
ACL	People to whom information is to be sent		20/03/23	185.94KB	Share
ACL	HLS: Off-market takeover bid from ACL	PRICE SENSITIVE	20/03/23	84.53KB	Share
ACL	Investor Webinar - Takeover Offer for Healius	PRICE SENSITIVE	20/03/23	129.09KB	Share
ACL	Investor Presentation - Takeover Offer for Healius	PRICE SENSITIVE	20/03/23	1.14MB	Share
ACL	Bidder's Statement in relation to Takeover Offer for Healius	PRICE SENSITIVE	20/03/23	5.25MB	Share
ACL	Takeover Offer for Healius Limited	PRICE SENSITIVE	20/03/23	364.62KB	Share
ACL	Notification regarding unquoted securities - ACL		17/03/23	26.57KB	Share
ACL	Change of Director's Interest Notice		17/03/23	1.09MB	Share
ACL	Notification regarding unquoted securities - ACL		17/03/23	25.69KB	Share
ACL	Notification of cessation of securities - ACL		17/03/23	21.47KB	Share
ACL	Ceasing to be a substantial holder		22/02/23	491.25KB	Share
ACL	Dividend/Distribution - ACL		20/02/23	25.92KB	Share
ACL	1H23 results investor presentation	PRICE SENSITIVE	20/02/23	1.57MB	Share
ACL	Appendix 4D and 1H23 financial reports	PRICE SENSITIVE	20/02/23	790.04KB	Share
ACL	1H23 Financial Results release details		13/02/23	300.16KB	Share
ACL	Release of Shares from Voluntary Escrow		09/02/23	220.99KB	Share
ACL	Medlab Cyber Incident Update		05/12/22	181.6KB	Share
ACL	Ceasing to be a substantial holder		22/11/22	85.6KB	Share
ACL	Becoming a substantial holder		11/11/22	89.56KB	Share
ACL	Medlab Pathology Cyber Incident		27/10/22	508.84KB	Share
ACL	2022 AGM - Results of Meeting		19/10/22	733.63KB	Share
ACL	2022 AGM - addresses to shareholders	PRICE SENSITIVE	19/10/22	1MB	Share
ACL	Change of Director's Interest Notice		07/10/22	1.08MB	Share
ACL	Director Appointment/Resignation		07/10/22	217.9KB	Share
ACL	Change of Director's Interest Notice		27/09/22	1.09MB	Share
ACL	Change of Director's Interest Notice		20/09/22	1.08MB	Share
ACL	Ceasing to be a substantial shareholder		16/09/22	123.16KB	Share
ACL	2022 Annual Report and Corporate Governance Statement		16/09/22	9.86MB	Share
ACL	Appendix 4G		16/09/22	727.73KB	Share
ACL	Notice of Annual General Meeting/Proxy Form		16/09/22	1.97MB	Share
ACL	Change of Director's Interest Notice		13/09/22	252.92KB	Share
ACL	Inclusion in S&P/ASX 300		07/09/22	217.5KB	Share
ACL	Change in substantial holding		05/09/22	121.42KB	Share
ACL	Update - Dividend/Distribution - ACL		05/09/22	26.11KB	Share
ACL	S&P DJI Announces September 2022 Quarterly Rebalance	PRICE SENSITIVE	02/09/22	134KB	Share
ACL	Change in substantial holding		26/08/22	284.94KB	Share
ACL	2022 AGM - Change of Date		22/08/22	216.94KB	Share
ACL	Ceasing to be a substantial holder		22/08/22	887.34KB	Share
ACL	Change in substantial holding		17/08/22	510.83KB	Share
ACL	Becoming a substantial holder		17/08/22	1.76MB	Share
ACL	Becoming a substantial holder		16/08/22	6.34MB	Share
ACL	Ceasing to be a substantial holder		15/08/22	76.9KB	Share
ACL	Change in substantial holding		15/08/22	134.67KB	Share
ACL	Second letter from Crescent Capital	PRICE SENSITIVE	12/08/22	405.53KB	Share
ACL	Letter received from Crescent Capital	PRICE SENSITIVE	12/08/22	513.69KB	Share
ACL	Dividend/Distribution - ACL		10/08/22	25.91KB	Share
ACL	FY22 Investor Presentation	PRICE SENSITIVE	10/08/22	1.29MB	Share
ACL	FY22 Financial Statements		10/08/22	4.49MB	Share
ACL	Appendix 4E - Preliminary Financial Report	PRICE SENSITIVE	10/08/22	159.04KB	Share
ACL	FY22 financial results - investor presentation webinar		04/08/22	189.67KB	Share
ACL	Release of Share from Voluntary Escrow		04/08/22	108.5KB	Share
ACL	Response to Market Enquiries	PRICE SENSITIVE	06/06/22	224.48KB	Share
ACL	Presentation to ASA Conference		23/05/22	1.07MB	Share
ACL	Change of Director's Interest Notice		28/04/22	1.09MB	Share
ACL	Change of Director's Interest Notice		28/04/22	1.08MB	Share
ACL	Change of Director's Interest Notice		28/04/22	1.08MB	Share
ACL	Update - Dividend/Distribution - ACL		21/04/22	26.04KB	Share
ACL	Becoming a substantial holder		20/04/22	132.7KB	Share

ACL 2023 Annual Report
21/09/23		7.52MB	Share
ACL 2023 AGM - Notice of Meeting
21/09/23		1.62MB	Share
ACL Update on offer for Healius and postponement of EGM
14/09/23		164.96KB	Share
ACL Chair - resumption of role
12/09/23		214.03KB	Share
ACL Ceasing to be a substantial holder
11/09/23		291.9KB	Share
ACL HLS: Supplementary Target's Statement
05/09/23	PRICE SENSITIVE	707.84KB	Share
ACL Becoming a substantial holder
28/08/23		816.91KB	Share
ACL Initial Director's Interest Notice - C Bartlett
23/08/23		966.91KB	Share
ACL Appointment of non-executive director
23/08/23		216.85KB	Share
ACL Notification regarding unquoted securities - ACL
22/08/23		24.81KB	Share
ACL Dividend/Distribution - ACL
22/08/23		22.48KB	Share
ACL FY23 investor results presentation
22/08/23	PRICE SENSITIVE	1.6MB	Share
ACL Appendix 4E and FY23 financial reports
22/08/23	PRICE SENSITIVE	2.97MB	Share
ACL 2023 AGM details
15/08/23		216.97KB	Share
ACL FY23 financial results investor webinar
15/08/23		130.82KB	Share
ACL HLS: ACCC Statement of Issues
20/07/23	PRICE SENSITIVE	138.1KB	Share
ACL Takeover bid for Healius Limited - extension of offer period
20/07/23	PRICE SENSITIVE	246.68KB	Share
ACL ACCC Statement of Issues - Offer for Healius Limited
20/07/23		347.99KB	Share
ACL AXX: ACL's proposed acquisition of Healius raises concerns
20/07/23	PRICE SENSITIVE	204.97KB	Share
ACL Initial Director's Interest Notice
05/07/23		231.14KB	Share
ACL Chair to take temporary leave
04/07/23		117.79KB	Share
ACL HLS: Directors' Statement re Takeover
23/05/23	PRICE SENSITIVE	142.59KB	Share
ACL Response to Healius' Target's Statement
22/05/23	PRICE SENSITIVE	176.33KB	Share
ACL Second Supplementary Bidder's Statement
22/05/23	PRICE SENSITIVE	3.05MB	Share
ACL Takeover offer - receipt of Target's Statement
05/05/23		121.44KB	Share
ACL HLS: Lodgement of Target's Statement
04/05/23	PRICE SENSITIVE	1.1MB	Share
ACL Completion of dispatch of replacement bidder's statement
21/04/23		124.62KB	Share
ACL Commencement of dispatch of replacement bidder's statement
21/04/23		6.13MB	Share
ACL Notice of EGM
20/04/23		8.33MB	Share
ACL TOV: HLS Panel Declines to Conduct Proceedings
17/04/23	PRICE SENSITIVE	93.48KB	Share
ACL ASX announcement - Replacement Bidder's Statement
14/04/23	PRICE SENSITIVE	208.73KB	Share
ACL Replacement Bidder's Statement
14/04/23	PRICE SENSITIVE	6.11MB	Share
ACL First Supplementary Bidder's Statement
14/04/23	PRICE SENSITIVE	6.36MB	Share
ACL Change in substantial holding
29/03/23		217.34KB	Share
ACL Change in substantial holding
29/03/23		1.77MB	Share
ACL TOV: HLS Panel Receives Application
29/03/23	PRICE SENSITIVE	114.08KB	Share
ACL Update - Dividend/Distribution - ACL
28/03/23		26.27KB	Share
ACL Becoming a substantial holder
27/03/23		374.34KB	Share
ACL Suspension of DRP
27/03/23		121.92KB	Share
ACL HLS: Directors' Statement re Takeover
27/03/23	PRICE SENSITIVE	171.75KB	Share
ACL Proposed issue of securities - ACL
22/03/23		25.31KB	Share
ACL Becoming a substantial holder for HLS
20/03/23		98.17KB	Share
ACL People to whom information is to be sent
20/03/23		185.94KB	Share
ACL HLS: Off-market takeover bid from ACL
20/03/23	PRICE SENSITIVE	84.53KB	Share
ACL Investor Webinar - Takeover Offer for Healius
20/03/23	PRICE SENSITIVE	129.09KB	Share
ACL Investor Presentation - Takeover Offer for Healius
20/03/23	PRICE SENSITIVE	1.14MB	Share
ACL Bidder's Statement in relation to Takeover Offer for Healius
20/03/23	PRICE SENSITIVE	5.25MB	Share
ACL Takeover Offer for Healius Limited
20/03/23	PRICE SENSITIVE	364.62KB	Share
ACL Notification regarding unquoted securities - ACL
17/03/23		26.57KB	Share
ACL Change of Director's Interest Notice
17/03/23		1.09MB	Share
ACL Notification regarding unquoted securities - ACL
17/03/23		25.69KB	Share
ACL Notification of cessation of securities - ACL
17/03/23		21.47KB	Share
ACL Ceasing to be a substantial holder
22/02/23		491.25KB	Share
ACL Dividend/Distribution - ACL
20/02/23		25.92KB	Share
ACL 1H23 results investor presentation
20/02/23	PRICE SENSITIVE	1.57MB	Share
ACL Appendix 4D and 1H23 financial reports
20/02/23	PRICE SENSITIVE	790.04KB	Share
ACL 1H23 Financial Results release details
13/02/23		300.16KB	Share
ACL Release of Shares from Voluntary Escrow
09/02/23		220.99KB	Share
ACL Medlab Cyber Incident Update
05/12/22		181.6KB	Share
ACL Ceasing to be a substantial holder
22/11/22		85.6KB	Share
ACL Becoming a substantial holder
11/11/22		89.56KB	Share
ACL Medlab Pathology Cyber Incident
27/10/22		508.84KB	Share
ACL 2022 AGM - Results of Meeting
19/10/22		733.63KB	Share
ACL 2022 AGM - addresses to shareholders
19/10/22	PRICE SENSITIVE	1MB	Share
ACL Change of Director's Interest Notice
07/10/22		1.08MB	Share
ACL Director Appointment/Resignation
07/10/22		217.9KB	Share
ACL Change of Director's Interest Notice
27/09/22		1.09MB	Share
ACL Change of Director's Interest Notice
20/09/22		1.08MB	Share
ACL Ceasing to be a substantial shareholder
16/09/22		123.16KB	Share
ACL 2022 Annual Report and Corporate Governance Statement
16/09/22		9.86MB	Share
ACL Appendix 4G
16/09/22		727.73KB	Share
ACL Notice of Annual General Meeting/Proxy Form
16/09/22		1.97MB	Share
ACL Change of Director's Interest Notice
13/09/22		252.92KB	Share
ACL Inclusion in S&P/ASX 300
07/09/22		217.5KB	Share
ACL Change in substantial holding
05/09/22		121.42KB	Share
ACL Update - Dividend/Distribution - ACL
05/09/22		26.11KB	Share
ACL S&P DJI Announces September 2022 Quarterly Rebalance
02/09/22	PRICE SENSITIVE	134KB	Share
ACL Change in substantial holding
26/08/22		284.94KB	Share
ACL 2022 AGM - Change of Date
22/08/22		216.94KB	Share
ACL Ceasing to be a substantial holder
22/08/22		887.34KB	Share
ACL Change in substantial holding
17/08/22		510.83KB	Share
ACL Becoming a substantial holder
17/08/22		1.76MB	Share
ACL Becoming a substantial holder
16/08/22		6.34MB	Share
ACL Ceasing to be a substantial holder
15/08/22		76.9KB	Share
ACL Change in substantial holding
15/08/22		134.67KB	Share
ACL Second letter from Crescent Capital
12/08/22	PRICE SENSITIVE	405.53KB	Share
ACL Letter received from Crescent Capital
12/08/22	PRICE SENSITIVE	513.69KB	Share
ACL Dividend/Distribution - ACL
10/08/22		25.91KB	Share
ACL FY22 Investor Presentation
10/08/22	PRICE SENSITIVE	1.29MB	Share
ACL FY22 Financial Statements
10/08/22		4.49MB	Share
ACL Appendix 4E - Preliminary Financial Report
10/08/22	PRICE SENSITIVE	159.04KB	Share
ACL FY22 financial results - investor presentation webinar
04/08/22		189.67KB	Share
ACL Release of Share from Voluntary Escrow
04/08/22		108.5KB	Share
ACL Response to Market Enquiries
06/06/22	PRICE SENSITIVE	224.48KB	Share
ACL Presentation to ASA Conference
23/05/22		1.07MB	Share
ACL Change of Director's Interest Notice
28/04/22		1.09MB	Share
ACL Change of Director's Interest Notice
28/04/22		1.08MB	Share
ACL Change of Director's Interest Notice
28/04/22		1.08MB	Share
ACL Update - Dividend/Distribution - ACL
21/04/22		26.04KB	Share
ACL Becoming a substantial holder
20/04/22		132.7KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.79		Change -0.015(0.54%)		Mkt cap ! $545.9M

Open	High	Low	Value	Volume
$2.79	$2.80	$2.78	$394.0K	141.6K

Buyers (Bids)

No.	Vol.	Price($)
11	20350	$2.78

Sellers (Offers)

Price($)	Vol.	No.
$2.79	9244	23

View Market Depth

No.	Vol.	Price($)
13	17260	2.780
11	41078	2.770
11	39449	2.760
15	35155	2.750
8	20861	2.740

Price($)	Vol.	No.
2.790	7545	17
2.800	15323	14
2.810	406	1
2.820	33812	9
2.830	12962	6

Last trade - 11.06am 31/07/2025 (20 minute delay)


Last $2.78		Change -0.015 ( 0.86 %)
Open	High	Low	Volume
$2.78	$2.80	$2.77	16076
Last updated 11.24am 31/07/2025 ?

ACL (ASX) Chart

AUSTRALIAN CLINICAL LABS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available